-
Toshiyuki Shoda
Division of Pathology, National Institute of Health Sciences, 1-18-1 Kamiyoga, Setagaya-ku, Tokyo 158-8501, Japan Section of Safety, Research Laboratories, Torii Pharmaceutical Co., Ltd. 1-2-1 Ohnodai, Midori-ku, Chiba-shi, Chiba 267-0056, Japan
-
Kunitoshi Mitsumori
Division of Pathology, National Institute of Health Sciences, 1-18-1 Kamiyoga, Setagaya-ku, Tokyo 158-8501, Japan
-
Tadakazu Takahashi
Section of Safety, Research Laboratories, Torii Pharmaceutical Co., Ltd. 1-2-1 Ohnodai, Midori-ku, Chiba-shi, Chiba 267-0056, Japan
-
Ken-ichi Horiuchi
Section of Safety, Research Laboratories, Torii Pharmaceutical Co., Ltd. 1-2-1 Ohnodai, Midori-ku, Chiba-shi, Chiba 267-0056, Japan
-
Yuji Yamazaki
Section of Safety, Research Laboratories, Torii Pharmaceutical Co., Ltd. 1-2-1 Ohnodai, Midori-ku, Chiba-shi, Chiba 267-0056, Japan
-
Yusuke Suzuki
Section of Safety, Research Laboratories, Torii Pharmaceutical Co., Ltd. 1-2-1 Ohnodai, Midori-ku, Chiba-shi, Chiba 267-0056, Japan
-
Yoshiaki Katsuda
Section of Safety, Research Laboratories, Torii Pharmaceutical Co., Ltd. 1-2-1 Ohnodai, Midori-ku, Chiba-shi, Chiba 267-0056, Japan
-
Yasuki Yokomoto
Section of Safety, Research Laboratories, Torii Pharmaceutical Co., Ltd. 1-2-1 Ohnodai, Midori-ku, Chiba-shi, Chiba 267-0056, Japan
-
Masateru Kurumi
Section of Safety, Research Laboratories, Torii Pharmaceutical Co., Ltd. 1-2-1 Ohnodai, Midori-ku, Chiba-shi, Chiba 267-0056, Japan